The Struggles of India’s Vaccine Giant

As the general midterm elections begin, we take a look at where things stand. A new Times/Siena poll suggests that Democrats have a real shot at winning control of both chambers of Congress. But serious obstacles stand in their way, including a financial disadvantage.The New York ...  Show more

For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ...  Show more

The world’s biggest vaccine manufacturer ended up with the world’s worst Covid-19 surge. Neha Arora, New Delhi correspondent for Reuters, explains. Transcript at vox.com/todayexplained. Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn ...  Show more

Facing a shortfall in vaccine supplies and slow pace of vaccinations, the EU is debating how to restrict exports of coronavirus vaccines, India’s farmers are angry about agricultural reforms that could erode the state-run model and boost private agribusiness, and the plant-bas ...

As wealthier nations have bought up most of the world’s supply of vaccines, many lower and middle-income countries have been left behind. Today, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta speaks to Dr. Krishna Udayakumar, Director of the Duke University Global Health Inno ...  Show more